Trunome is a healthcare technology company that aims to make personalized medicine and genetic testing more accessible and affordable to patients. The company is focused on developing technologies that can provide point-of-care pharmacogenomics and genomic diagnostics tests. Trunome is based in Chennai, Tamil Nadu, India, and was founded in 2018 by Agragesh R and Avinash Ramani.
Trunome’s genetic predisposition tests are designed to help individuals make informed decisions about their health and lifestyle. By analyzing a patient’s genetic information, Trunome can identify potential health risks and provide recommendations for managing and mitigating those risks. The company’s tests can also help healthcare providers personalize treatments based on a patient’s genetic makeup.
Trunome’s business model is B2B2C, with a focus on serving the needs of the healthcare industry. The company targets biotech/biopharmaceutical and healthtech/medtech/healthcare companies, particularly large enterprises. Trunome also serves hospitals and doctors, providing them with the tools and information they need to treat patients more effectively. The company’s user base spans a range of ages, incomes, and geographic locations, including India, Asia Pacific, Europe, North America, and beyond.
Since its founding, Trunome has won several awards and participated in an accelerator/incubator program. In 2020, the company raised INR 2 crore in a combination of debt and equity funding. Trunome generates revenue through licensing, physical commerce, subscription fees, and fee-for-service arrangements.
Trunome’s core team includes Agragesh R as Co-Founder and CEO, and Avinash Ramani as Co-Founder. The company has between 11 and 20 employees and is headquartered in Chennai, Tamil Nadu, India. Its investors include V C Karthik and Mahesh Kanumury.
Shark Tank India: Trunome Complete Review
Trunome is a clinical genomics company that operates under the formal name of Acrannolife Genomics Pvt Ltd. The company’s main focus is on providing personalized medicine and genetic testing to the healthcare industry through the use of new technologies in an affordable and sustainable manner. Their vision is to develop technologies that enable the most affordable point-of-care pharmacogenomics and genomic diagnostics tests, which would revolutionize healthcare in India.
Trunome was founded in 2018 in Chennai by Agragesh Ramani and Avinash Ramani, who are also the core team members of the company. Trunome operates on a B2B2C model, which allows them to serve the needs of hospitals and doctors while providing better treatment for patients. Their genetic predisposition tests can help patients make informed decisions about their health and adjust their lifestyle accordingly.
Trunome was featured in Shark Tank India Season 2, Week 9, Episode 41. However, as of the airing of the episode, details such as the company’s ask, deal, valuation, and investor names were not yet available. It remains to be seen whether the sharks will be impressed by Trunome’s technology and invest in the company.
Overall, Trunome has created an innovative business that focuses on timely diagnosis and the provision of transplants for chronic and chronic diseases. The Shark Tank India program aims to inspire viewers to think of similar businesses by adding case studies of other successful companies such as Janitri.